Evidence map›Paper›PMID 33195565›Full record

ReviewFrontiers in veterinary science2020

Phytogenic Products and Phytochemicals as a Candidate Strategy to Improve Tolerance to Coronavirus.

Youssef A Attia, Mahmoud M Alagawany, Mayada R Farag, Fatmah M Alkhatib, Asmaa F Khafaga, Abdel-Moneim Eid Abdel-Moneim, Khalid A Asiry, Noura M Mesalam, Manal E Shafi, Mohammed A Al-Harthi and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in veterinary science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Antioxidant and antimicrobial activities ofSaudi journal of biological sciences · 2022
    Article
  16. Article
  17. Article
  18. Molecular docking study of variousFrontiers in microbiology · 2022
    Article
  19. Review
  20. Effect of Dietary Ramie Powder (Frontiers in physiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Youssef A AttiaAgriculture Department, Faculty of Environmental Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Mahmoud M AlagawanyDepartment of Poultry, Faculty of Agriculture, Zagazig University, Zagazig, Egypt.
Mayada R FaragForensic Medicine and Toxicology Department, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
Fatmah M AlkhatibChemistry Department, Faculty of Applied Science, UmmAl-Qura University, Makkah, Saudi Arabia.
Asmaa F KhafagaDepartment of Pathology, Faculty of Veterinary Medicine, Alexandria University, Edfina, Egypt.
Abdel-Moneim Eid Abdel-MoneimBiological Application Department, Nuclear Research Center, Atomic Energy Authority, Abu-Zaabal, Egypt.
Khalid A AsiryAgriculture Department, Faculty of Environmental Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Noura M MesalamBiological Application Department, Nuclear Research Center, Atomic Energy Authority, Abu-Zaabal, Egypt.
Manal E ShafiDepartment of Biological Sciences, Zoology, King Abdulaziz University, Jeddah, Saudi Arabia.
Mohammed A Al-HarthiAgriculture Department, Faculty of Environmental Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Mohamed E Abd El-HackDepartment of Poultry, Faculty of Agriculture, Zagazig University, Zagazig, Egypt.
King Abdulaziz University · SAZagazig University · EGEgyptian Atomic Energy Authority · EGAlexandria University · EGDamanhour University · EGUmm al-Qura University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronaviruses are the causative agents of many infectious diseases in human and animals. These included severe acute respiratory syndrome (SARS), avian infectious bronchitis (IBV) in poultry, Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19) in humans. These results had considerable death burdens and negative influences on social-economic life. Since the appearance of the outbreak of the COVID-19 pandemic, continuous investigations have been carried out by researchers to find active compounds, mainly from plants, as natural sources, that could inhibit or stop the proliferation of the causative agent of COVID-19 (SARS-CoV-2). The most common symptoms caused by infections with COVID-19 can include cough, fever, and sore throat. Nevertheless, there is a shortage of active antiviral compounds for treating different strains of coronavirus. Herbal medicine is a class of medication that originates from nature and is aimed at decreasing the use of preservatives, excipients, or other additives and, consequently, lesser side effects. The rapid spread of COVID-19 infection besides the lack of knowledge about any treatments and the growing concern of the public from the virus directed us toward writing this review article in an aim to provide alternatives to the allopathic medicine use. There is a wealth of chemical diversity in the naturally existing compounds, including their antiviral activities, which may encourage their utilization as therapeutics against viral infections, including coronaviruses. The majority of publications on the herbal remedies of coronavirus, MERS, or SARS focused primarily on the use of polar compounds. These substances displayed encouraging inhibitory influences on coronavirus in humans. These include psoralidin, scutellarein, silvestrol, tryptanthrin, caffeic acid, quercetin, myricetin, saikosaponin B2, griffithsin (lectins), and isobavachalcone. Some other agents like lycorine may be useful, if the antiviral activity is obtained by concentrations below the toxic plasma levels. According to the available literatures, the most promising inhibitors of coronaviruses are polyphenolic compounds, which are small molecules with conjugated fused ring structures.

Indexed as

COVID-19healthimmunityphytochemicalsphytogenic additiveSARS-CoV-2

Identifiers

PMID33195565
PMCPMC7606864
OpenAlexW3094025280

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.